Mobilization of Stem Cells With G-CSF and Mozobil in Patients With End Stage Liver Disease

Status unconfirmed · Phase 1

Conditions studied: End Stage Liver DIsease

In brief

A phase I trial to study the safety of mobilization of stem cells with G-CSF and Mozobil in patients with chronic liver disease.

Key facts

Study ID
NCT01711073
Run by
Proteonomix, Inc.
People needed
15
Starts
2012-10-01
Expected to finish
2013-09-01
Last updated by the study team
2013-01-24

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.